These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 8263755)
1. Lack of association between anti-V3 loop antibody and perinatal HIV-1 transmission in Kinshasa, Zaire, despite use of assays based on local HIV-1 strains. St Louis ME; Pau CP; Nsuami M; Ou CY; Matela B; Kashamuka M; Brown C; George JR; Heyward WL J Acquir Immune Defic Syndr (1988); 1994 Jan; 7(1):63-7. PubMed ID: 8263755 [TBL] [Abstract][Full Text] [Related]
2. Pattern of antibody response against the V3 loop in children with vertically acquired immunodeficiency virus type 1 (HIV-1) infection. De Rossi A; Zanotto C; Mammano F; Ometto L; Del Mistro A; Chieco-Bianchi L AIDS Res Hum Retroviruses; 1993 Mar; 9(3):221-8. PubMed ID: 7682425 [TBL] [Abstract][Full Text] [Related]
3. Evidence of no change in V3 loop antibody recognition pattern in HIV type 1-infected Ethiopians between 1988 and 1993. Sherefa K; Sällberg M; Sönnerborg A AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1551-6. PubMed ID: 7534097 [TBL] [Abstract][Full Text] [Related]
4. Maternal Binding and Neutralizing IgG Responses Targeting the C-Terminal Region of the V3 Loop Are Predictive of Reduced Peripartum HIV-1 Transmission Risk. Martinez DR; Vandergrift N; Douglas AO; McGuire E; Bainbridge J; Nicely NI; Montefiori DC; Tomaras GD; Fouda GG; Permar SR J Virol; 2017 May; 91(9):. PubMed ID: 28202762 [TBL] [Abstract][Full Text] [Related]
5. Correlation of maternal cytophilic human immunodeficiency virus (HIV)-1 V3 loop peptide-specific antibodies in infants with vertical HIV transmission. Wang XP; Oyaizu N; Pahwa S Pediatr Res; 1995 Sep; 38(3):384-9. PubMed ID: 7494664 [TBL] [Abstract][Full Text] [Related]
6. Lack of correlation between maternal antibodies to V3 loop peptides of gp120 and perinatal HIV-1 transmission. The NYC Perinatal HIV Transmission Collaborative Study. Parekh BS; Shaffer N; Pau CP; Abrams E; Thomas P; Pollack H; Bamji M; Kaul A; Schochetman G; Rogers M AIDS; 1991 Oct; 5(10):1179-84. PubMed ID: 1786145 [TBL] [Abstract][Full Text] [Related]
7. Reactions of Ugandan antisera with peptides encoded by V3 loop epitopes of human immunodeficiency virus type 1. Smith JD; Bruce CB; Featherstone AS; Downing RG; Biryahawaho B; Clegg JC; Carswell JW; Oram JD AIDS Res Hum Retroviruses; 1994 May; 10(5):577-83. PubMed ID: 7522494 [TBL] [Abstract][Full Text] [Related]
8. Maternofetal transmission of human immunodeficiency virus-1: the role of antibodies to the V3 primary neutralizing domain. Rubinstein A; Goldstein H; Calvelli T; Devash Y; Rubinstein R; Soeiro R; Lyman W Pediatr Res; 1993 Jan; 33(1 Suppl):S76-8; discussion S78-9. PubMed ID: 8433879 [TBL] [Abstract][Full Text] [Related]
9. Antibodies to V3 loop peptides derived from chimpanzee lentiviruses and the divergent HIV-1ANT-70 isolate in human sera from different geographic regions. Peeters M; Nkengasong J; Willems B; Karita E; Delaporte E; Van den Haesevelde M; Piot P; van der Groen G AIDS; 1994 Dec; 8(12):1657-61. PubMed ID: 7888113 [TBL] [Abstract][Full Text] [Related]
10. Maternal antibodies to HIV-1 envelope domains: No correlation with HIV-1 vertical transmission in patients from Argentina. Calarota SA; Libonatti OV Scand J Immunol; 2000 Sep; 52(3):292-7. PubMed ID: 10972906 [TBL] [Abstract][Full Text] [Related]
11. V3 sequence diversity of HIV-1 subtype E in infected mothers and their infants. Sutthent R; Foongladda S; Chearskul S; Wanprapa N; Likanonskul S; Kositanont U; Riengrojpitak S; Sahaphong S; Wasi C J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(4):323-31. PubMed ID: 9704937 [TBL] [Abstract][Full Text] [Related]
12. A survey of synthetic HIV-1 peptides with natural and chimeric sequences for differential reactivity with Zimbabwean, Tanzanian and Swedish HIV-1-positive sera. Blomberg J; Lawoko A; Pipkorn R; Moyo S; Malmvall BE; Shao J; Dash R; Tswana S AIDS; 1993 Jun; 7(6):759-67. PubMed ID: 8363754 [TBL] [Abstract][Full Text] [Related]
13. High antigenic cross-reactivity of the V3 consensus sequences of HIV-1 gp120. Baillou A; Brand D; Denis F; M'Boup S; Chout R; Goudeau A; Barin F AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1209-15. PubMed ID: 7511395 [TBL] [Abstract][Full Text] [Related]
15. High prevalence of antibodies to the gp120 V3 region principal neutralizing determinant of HIV-1MN in sera from Africa and the Americas. Carrow EW; Vujcic LK; Glass WL; Seamon KB; Rastogi SC; Hendry RM; Boulos R; Nzila N; Quinnan GV AIDS Res Hum Retroviruses; 1991 Oct; 7(10):831-8. PubMed ID: 1720630 [TBL] [Abstract][Full Text] [Related]
16. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies. Chakraborty K; Durani V; Miranda ER; Citron M; Liang X; Schleif W; Joyce JG; Varadarajan R Biochem J; 2006 Nov; 399(3):483-91. PubMed ID: 16827663 [TBL] [Abstract][Full Text] [Related]
17. Lack of association between maternal antibodies to V3 loop peptides and maternal-infant HIV-1 transmission. Halsey NA; Markham R; Wahren B; Boulos R; Rossi P; Wigzell H J Acquir Immune Defic Syndr (1988); 1992; 5(2):153-7. PubMed ID: 1732507 [TBL] [Abstract][Full Text] [Related]
18. Maternal HIV-1 antibody and vertical transmission in subtype C virus infection. Guevara H; Casseb J; Zijenah LS; Mbizvo M; Oceguera LF; Hanson CV; Katzenstein DA; Hendry RM J Acquir Immune Defic Syndr; 2002 Apr; 29(5):435-40. PubMed ID: 11981358 [TBL] [Abstract][Full Text] [Related]
19. Lack of association between anti-V3 loop antibodies and perinatal transmission of HIV-1 in Kampala, Uganda. Epstein H; Guay L; Hom D; Mmiro F; Ndugwa C; Marum L; Olness K; Piwowar E; Kataaha P; Baenziger J Pediatr AIDS HIV Infect; 1994 Dec; 5(6):350-6. PubMed ID: 11361376 [TBL] [Abstract][Full Text] [Related]
20. Mother to child transmission of HIV-1 in a Thai population: role of virus characteristics and maternal humoral immune response. Kittinunvorakoon C; Morris MK; Neeyapun K; Jetsawang B; Buehring GC; Hanson CV J Med Virol; 2009 May; 81(5):768-78. PubMed ID: 19319941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]